Fortress Biotech Inc (NAS:FBIO)
$ 1.7 0.03 (1.8%) Market Cap: 32.70 Mil Enterprise Value: 35.86 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 50/100

Fortress Biotech Inc at ROTH Conference Transcript

Mar 13, 2023 / 04:00PM GMT
Release Date Price: $10.67 (-1.24%)
Scott Henry
ROTH MKM Partners - Analyst

Okay, thank you and good morning. My name is Scott Henry, healthcare analyst at ROTH MKM Partners. Thank you for joining this fireside chat, which will also be webcast. Our focus company is Fortress Biotech; ticker, FBIO; market cap, approximately $100 million. Participating from the company is Lindsay Rosenwald, CEO and Chairman. Let's get started.

Lindsay, thank you for coming to the ROTH Conference. Could you take a couple of minutes to tell us about Fortress? After that, we'll open it up for discussion. We have about 25 minutes. (Conference Instructions) Thank you. Lindsay?

Lindsay Rosenwald
Fortress Biotech, Inc. - Chairman, President & CEO

Sure. So Fortress is certainly a different kind of life science company. I've been in the business a long time. I know it's an incredibly risky business, and I'm incredibly risk averse. So it's -- when I took over what became Fortress, I decided to build something that we could focus on risk aversion, and at the same time, focus on potential great growth and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot